New system of scoring IQ tests taken by children with fragile X syndrome
The George Washington University has announced the establishment of the GW Institute for Nanotechnology. This institute will draw on the expertise of the University’s faculty members in mechanical, aerospace, electrical, computer, civil, and environmental engineering; physics, chemistry; and biochemistry. The institute is supported through special endowment funding designated for academic programs with the potential for
Full Post: A new Institute for Nanotechnology
Parents of children with intellectual disabilities have long been frustrated by intelligence quotient (IQ) testing that tells them little to nothing about the long-term learning potential of their children.
That’s because these tests are scored according to the mean performance of children without disabilities. The result is that the raw scores of many children with intellectual disabilities are converted into the lowest normalized score, typically a zero.
“We send back these reports that don’t tell parents anything about their child,” explained David Hessl, an associate professor of clinical psychiatry and a researcher at the UC Davis M.I.N.D. Institute.
Hessl and a team of collaborators have devised a new system of scoring IQ tests taken by children with fragile X syndrome, a genetic disorder that causes intellectual disabilities, including autism. The details of the new method are described in a study published online today by the Journal of Neurodevelopmental Disorders .
“If this new method becomes widely available, we will be able to tell parents something more useful and more accurately diagnose and treat young children who are learning disabled,” said Hessl, a physician who cares for children at the M.I.N.D. Institute with fragile X syndrome.
According to Hessl, there is a lot of meaningful variability in the performance of these children on IQ tests.
“We believe that this variability is important information about the relative strengths and weaknesses that these children have,” Hessl explained. Frustrated by the lack of sensitivity of IQ tests, Hessl set out to devise a scoring method that would reveal the strengths and weaknesses of each child.
“I knew a more accurate estimation of the potential of these children would make a big difference in their lives,” he said.
Hessl worked with fragile X researchers at the M.I.N.D. Institute and Stanford University, as well as a statistician from Pennsylvania State University. The team came up with new normalized scores for 217 children with fragile X syndrome who had undergone IQ testing.
Many of these children had normalized scores of 0 on the Wechsler Intelligence Scale for Children, an intelligence test for children between the ages of 6 and 16 that can be completed without reading or writing.
On the new scale, children scored as low as minus 10 on 14 subtests. These included verbal, arithmetic, picture completion and object assembly.
Like normalized scores of children without disabilities, the frequency of the new normalized scores for children with fragile X syndrome followed an expected, bell-shaped distribution.
“These new scores tell us more precisely how a child with fragile x syndrome deviates from the normal population in every sub-test area,” Hessl said.
Physicians and parents also need to know that these new scores reflect something about the biology of the children.
So, the research team went on to compare the new normalized scores to a measure of adaptive behavior and a biological measure of the severity of fragile X syndrome. Without a normal copy of the fragile X gene, a vital protein (FMR1 protein, or FMRP) is not made and the result is the onset of characteristic mental disorders, which can range from learning disabilities to severe cognitive or intellectual disabilities, such as autism.
Hessl and his colleagues compared the levels of FMRP in blood from the test subjects to their new scores and found a significant correlation. They found similarly significant correlations between the IQ test scores and scores on the Vineland Adaptive Behavior Composite, which measures personal and social skills used in everyday living.
Treatment of fragile X syndrome depends on its manifestations in the individual, and range from behavioral therapy to medication. Widespread use of new normalized scores would allow physicians to better treat their patients, Hessl said.
Psychological Corporation, the publishers of the Wexler IQ test, gave permission for their raw date to be used in the context of research.
“I think we’ve made a good case for the makers of this test and others to release raw data to researchers so that this method can be applied to other populations with intellectual disabilities,” Hessl said.
He is also hopeful that someday soon he will get permission to use his new scoring method when treating his patients. In the future, the publishers of IQ tests should include lower-functioning individuals in their standardization studies, Hessl said.
“This might mean over-sampling those with intellectual disability in order to get more sensitivity, but it would help so many children,” he said.
Parents of children with intellectual disabilities have long been frustrated by IQ testing that tells them little to nothing about their children’s long-term learning potential. That’s because the tests are scored according to the mean performance of children without disabilities, so the raw scores of many intellectually disabled children are converted to the lowest normalized
Full Post: New system of scoring IQ tests benefits children with intellectual disabilities
Writing in this week’s Journal of the American Medical Association , UC Davis M.I.N.D. Institute researchers urge physicians to test for mutations of the fragile X gene in patients of all ages. That’s because, after decades of research, it is clear that mutations in this gene cause a range of diseases, including neurodevelopmental delays and
Full Post: Researchers urge physicians to test for fragile X gene mutations in patients of all ages
A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS). Findings of the open label, single-dose study by researchers at Rush University Medical Center and the University of California, Davis, Medical Center are to
Full Post: New drug being tested for Fragile X syndrome
Predictive medicine company PreMD Inc. has announced that it has filed a provisional patent application that describes a new simplified method of quantifying immunohistochemical staining of biomarkers. The provisional patent application was filed with the United States Patent and Trademark office. This application, based on PreMD’s existing colour measurement patents and patent applications, may
Full Post: PreMD files provisional patent application for new method of quantifying cancer biomarkers
New research by British scientists means prenatal testing for autism is a possibility, but has evoked calls for an ethical debate on the issue. A study by researchers at the autism research centre of Cambridge University has found that high levels of testosterone in the amniotic fluid of pregnant women was linked to autistic traits,
Full Post: Possible test for autism raises calls for an ethical debate